RSS

Brexit

With recent plans announced by the UK’s prime minister to remain part of the EMA, which would be favourable for many in the pharma industry, I will look at these developments as well as how they will impact industry and the reactions from leaders more

Opinion

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Independent advocate for science and engineering, CaSE, has published a new Brexit report with policy requests from the science and engineering sector on people, funding and regulation, to mark the anniversary of the triggering of article 50. more

News

As the guidelines for the negotiations of future relations between the EU and the UK are approved, allowing the progression of Brexit talks, pharma, biotech and manufacturing industry leaders give their opinions on the transition. more

Opinion

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

The associations representing the UK’s pharma and biotech industries have announced their support of the recently published findings of the new Health and Social Care Committee report into Brexit. more

News

The ‘Amazon Effect’, new address systems and Brexit are driving change, in this online opinion article, BluJay Solutions presents the three most important trends to prepare for in 2018. more

Opinion

In this article, NSF International goes into detail about what the potential ramifications of Brexit may be on the regulatory landscape in pharma. more

Opinion

Here, Vikash Patel, senior regulatory specialist for ELC Group, gives us an update on the regulatory developments impacting the pharma industry as a result of Brexit. more

Opinion

Developer and manufacturer of bioscience products, Stream Bio, will be joining the PM, Theresa May, and other select UK businesses, on the international trade visit to China. more

News

The Brexit Health Alliance (BHA) has urged for regulatory arrangements to be made as a matter of urgency to prevent any potential risk to public health as a result of Brexit. more

Analysis

The Association of the British Pharmaceutical Industry (ABPI) has issued its reaction to the publication of the Medicines and Healthcare products Regulatory Agency’s (MHRA) update to pharma companies on preparing for Brexit. more

News

The manufacturers’ organisation, EEF, has revealed that secretary of state for international trade, Liam Fox, will be a keynote political speaker at this year’s National Manufacturing Conference taking place in London on 20 February. more

News

A recently published survey has demonstrated an optimistic outlook of a growing global economy that will sustain new orders and industry growth by British manufacturers. more

Analysis

With festivities and holidays galore during the latter part of December we thought it would be a good idea to briefly run through some of the pharma news that came out in the run up to Christmas. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

To coincide with the House of Commons Health Select Committee hearing evidence on ‘Brexit: the regulation of medicines, medical devices and substances of human origin’, the ABPI and the BIA release research on impact of UK’s exit from Europe more

News

As Brexit moves to the next phase, thanks to ‘sufficient progress’ being made in phase one of the negotiations as announced by the European Commission president Jean-Claude Juncker and prime minister Theresa May, some industry bodies welcome the news more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Written evidence has been published by the Business, Energy and Industrial Strategy Committee, suggesting the impact Brexit may have on the pharmaceutical industry. more

News